COVID-19 Information: Vaccine | Testing | Self-assessment | Patient & Visitor Safety | Visitor Policy
Emergency Room Wait Times
Home > Clinical Trials > Clinical Trial Search Results
Study evaluating the addition of 2 years of palbocicilib to standard adjuvant endocrine therapy for patients with HR+/HER2 early breast cancer (EBC).
Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.
Set Your Location
Setting your location helps us to show you nearby providers and locations based on your healthcare needs.